tradingkey.logo

China Pharma Holdings Inc

CPHI
View Detailed Chart

1.985USD

+0.020+1.02%
Close 09/19, 16:00ETQuotes delayed by 15 min
6.48MMarket Cap
LossP/E TTM

China Pharma Holdings Inc

1.985

+0.020+1.02%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.02%

5 Days

+9.26%

1 Month

+40.28%

6 Months

-29.31%

Year to Date

-14.62%

1 Year

-9.69%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered undervalued,and institutional recognition is very high. Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
124 / 175
Overall Ranking
497 / 4720
Industry
Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.53M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 19.22.
Fairly Valued
The company’s latest PE is -0.67, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 721.01K shares, increasing 7.77% quarter-over-quarter.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Ticker SymbolCPHI
CompanyChina Pharma Holdings Inc
CEOMs. Zhilin Li
Websitehttp://www.chinapharmaholdings.com
KeyAI